Blog
RSS FeedPosted by Michael Wonder on 17 Aug 2016
Promise and plausibility: health technology adoption decisions with limited evidence
18 August 2016 - The adoption of new medical devices and diagnostics is often hampered by lack of published evidence which ...
Posted by Michael Wonder on 17 Aug 2016
Proposed new drug guidelines for the PBS put cost-cutting before patients
17 August 2016 - The sustained accessibility of Australians to world-class medicines will be in question if proposed drug review guidelines ...
Posted by Michael Wonder on 15 Aug 2016
Better monitoring of biological medicines
15 August 2016 - New chapter in guidelines on good pharmacovigilance practices. ...
Posted by Michael Wonder on 11 Aug 2016
A novel UK approach to cancer access: yes, no, or maybe?
10 August 2016 - What are the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients? ...
Posted by Michael Wonder on 11 Aug 2016
CADTH provides an update on its therapeutic review of new drugs for type 2 diabetes mellitus
10 August 2016 - CADTH is undertaking a project to assess the clinical and cost-effectiveness of new drugs for the treatment ...
Posted by Michael Wonder on 10 Aug 2016
Cancer patients may lose vital drug in crackdown on funding: watchdog reviews 31 treatments that are not usually available on the NHS
10 August 2016 - The drug brentuximab vedotin may no longer be provided on the NHS. ...
Posted by Michael Wonder on 06 Aug 2016
FDA issues draft updated recommendations on submitting a new 510(k) for device modifications
5 August 2016 - The U.S. FDA today issued draft updated recommendations to help manufacturers determine when they are required to ...
Posted by Michael Wonder on 05 Aug 2016
PBAC Guidelines review update
5 August 2016 - The PBAC Guidelines Review is anticipated to be completed by November 2016. ...
Posted by Michael Wonder on 03 Aug 2016
New layout for EMA scientific guidelines
2 August 2016 - Improved presentation to help website users. ...
Posted by Michael Wonder on 30 Jul 2016
A pill too hard to swallow: how the NHS is limiting access to high priced drugs
27 July 2016 - A joint investigation by The BMJ and Cambridge and Bath universities uncovers how NHS England tried to ...
Posted by Michael Wonder on 30 Jul 2016
FDA approvals for the first 6 months of 2016
29 July 2016 - The FDA approved 13 new drugs in the first 6 months of this year. ...
Posted by Michael Wonder on 30 Jul 2016
Controversial CDF revamp launches
29 July 2016 - England's Cancer Drugs Fund reopens under its new model today, but the pharma industry and charities are ...
Posted by Michael Wonder on 28 Jul 2016
Sigma backs Productivity Commission’s federal pharmacy review
28 July 2016 - Sigma Pharmaceuticals has backed a federal government-sanctioned review into the sector, saying it is timely to take ...
Posted by Michael Wonder on 27 Jul 2016
Ensuring Australians get most from community pharmacy
27 July 2016 - The Australian Government is ensuring Australians get the best experience possible from community pharmacy and wants to ...
Posted by Michael Wonder on 27 Jul 2016
Review process is an opportunity for pharmacy
27 July 2016 - The release of the discussion paper of the Review of Pharmacy Remuneration and Regulation is an important ...